KMS Medisurgi IPO is a Fixed Price IPO listing on BSE SME exchange, with an ipo size of ₹ 2.70 Cr. The company is based in Mumbai and caters to Healthcare sector. Navigant Corporate Advisors is the merchant banker of KMS Medisurgi IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th September 2016.
KMS Medisurgi IPO open date is 12th April 2017 and close date is 17th April 2017. IPO Allotment Date is 30th November -0001 and Listing date is 24th April 2017.KMS Medisurgi IPO size is ₹ 2.70 Cr. with IPO price of ₹ 30.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Navigant Corporate Advisors Limited is the book-running lead manager of the KMS Medisurgi IPO. Kfin Technologies Limited is the Registrar and Market Maker is Naysaa Securities Limited for KMS Medisurgi IPO.
KMS Medisurgi IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
KMS Medisurgi IPO, based in Mumbai, operates in the Healthcare sector with a focus on equipment and medical services. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. KMS Medisurgi IPO size is ₹ 2.70 Cr. with fresh issue size of ₹ 3 and Offer for sale being ₹ Nil
The IPO allotment date for KMS Medisurgi IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check KMS Medisurgi IPO allotment status on the registrars website, Kfin Technologies Limited . KMS Medisurgi IPO refund dates are 30th November -0001.
KMS Medisurgi IPO is expected to be listed on 24th April 2017.
The upper price band for the KMS Medisurgi IPO is set at ₹ 30.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on KMS Medisurgi IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the KMS Medisurgi IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 17th April 2017. After submission, funds are blocked until the basis of allotment of KMS Medisurgi IPO is finalised.
The merchant banker for KMS Medisurgi IPO is Navigant Corporate Advisors Limited . Navigant Corporate Advisors Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the KMS Medisurgi IPO RHP for further details.
The registrar for KMS Medisurgi IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to KMS Medisurgi IPO through their official website or helpline.
KMS Medisurgi IPO was subscribed 0.00 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
KMS Medisurgi IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on KMS Medisurgi Financial Review Page
Merchant Banker(s) of KMS Medisurgi IPO: Navigant Corporate Advisors Limited
KMS Medisurgi IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
KMS Medisurgi IPO listed at a listing price of 30.50 against the offer price of 30.00.
The current market price of KMS Medisurgi is 126.90.
Why Us?